OIS Podcast - Dompé’s Long-Term Approach

On this episode of the OIS Podcast ExSight’s co-founder, Dr. Firas Rahhal, sits down with Gianluca Rossetti, Strategic Planning & Corporate Business Development Director at Dompé. The two discuss Dompé’s storied 130-year history, keys to surviving and succeeding global challenges, views to the future, and the all-or-nothing nature of drug development.

A patient, long-term view is both a key component of Investing in early-stage innovation and central to ExSight’s founding principles. Firas and Gianluca discuss their shared belief in that premise and how managing toward long-term impact has underpinned Dompé’s success. The patience required for therapeutic development and long-term innovation though must be countered with an urgency and lack of complacency with existing technologies. Gianluca discusses how Dompé’s Exscalate program is expediting the arduous therapeutic development process.

This episode of the OIS Podcast provides additional insights into Dompé’s expansion plan, relative advantages of a family-owned company, Oxervate’s success, and much more. Listen